FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma

With this approval, patients with advanced/metastatic MCC will now have another treatment option.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news